Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis

James W. Verbsky, Andrew J. White

Research output: Contribution to journalArticlepeer-review

157 Scopus citations

Fingerprint Dive into the research topics of 'Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences